RAD — Radiopharm Theranostics Share News
0.000.00%
Last trade - 00:00- AU$15.95m
- AU$9.45m
- AU$2.77m
Australia's Starpharma jumps on plans to develop novel radiotherapy treatment
Brief: Starpharma Holdings Signs Research And Option Agreement With Radiopharm Theranostics
Brief: Radiopharm Theranostics Reports FY Loss Attributable A$36.7 Million
Brief: Radiopharm Theranostics Confirmed Guidance Of Cash Runway Through To Mid-2026
Brief: Radiopharm Theranostics To Start Rv-01 Study In 4Q25
Brief: Radiopharm Theranostics Receives IND Approval From US FDA For Betabart (Rv-01)
Brief: Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
Brief: Radiopharm Theranostics Signs Supply Agreement With Cyclotek
Australia's Radiopharm Theranostics jumps on FDA's Fast Track Designation for product
Brief: Radiopharm Theranostics Says Rad Granted Us FDA Fast Track For Rad101 Metastases Imaging
Brief: Radiopharm Theranostics Says ITM Isotope Technologies Munich SE And Co Sign Supply Agreement
Brief: Radiopharm Theranostics Logs HY Loss From Ordinary Activities A$18.7 Mln
Brief: New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
Brief: Lantheus Increases To 12.16% Shareholding In Radiopharm With US$5M (A$8M) Placement
Australia's Radiopharm Theranostics jumps on securing premium placement from US co Lantheus
Brief: Radiopharm Theranostics Says Lantheus Increases Shareholding In Co
Development Partnership With Lantheus
Australia's Radiopharm Theranostics rises on partnership with Lantheus
Brief: Radiopharm Achieves Nasdaq Listing Of American Depositary Shares